Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Schindewolf

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Diagnostics (Basel, Switzerland)|September 14, 2024
Using Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as a Rescue Strategy in Severe Postpartum Hemorrhage: A Case ReportSophie-Kristin Brauer, Alexandre Athanasios Musy, Sophie Schneider, et al.
Circulation|October 18, 2022
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized TrialYann Gouëffic, Giovanni Torsello, Thomas Zeller, et al.
Thrombosis and Haemostasis|January 17, 2025
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE EuropeGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
Journal of the American College of Cardiology|November 25, 2017
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis Research|April 8, 2014
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry studyMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2026
Visual analysis of [<sup>18</sup>F]FDG PET/CT imaging yields superior diagnostic accuracy compared to semiquantitative analysis in the assessment of giant cell arteritisLuca Seitz, Rahel Friedli, Nasir Gözlügöl, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
NPJ Genomic Medicine|February 7, 2024
A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genomeClaude Bhérer, Robert Eveleigh, Katerina Trajanoska, et al.
Cardiovascular Research|November 20, 2025
ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage like foam cells in atherosclerosisBryce R Evans, Julia Schulz, Vasiliki Triantafyllidou, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|September 14, 2024
Using Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as a Rescue Strategy in Severe Postpartum Hemorrhage: A Case ReportSophie-Kristin Brauer, Alexandre Athanasios Musy, Sophie Schneider, et al.
Circulation|October 18, 2022
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized TrialYann Gouëffic, Giovanni Torsello, Thomas Zeller, et al.
Thrombosis and Haemostasis|January 17, 2025
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE EuropeGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
Journal of the American College of Cardiology|November 25, 2017
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced ThrombocytopeniaMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
Thrombosis Research|April 8, 2014
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry studyMarc Schindewolf, Julia Steindl, Jan Beyer-Westendorf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2026
Visual analysis of [<sup>18</sup>F]FDG PET/CT imaging yields superior diagnostic accuracy compared to semiquantitative analysis in the assessment of giant cell arteritisLuca Seitz, Rahel Friedli, Nasir Gözlügöl, et al.
European Journal of Internal Medicine|August 23, 2020
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countriesAlexander T Cohen, Ulrich Hoffmann, Philippe Hainaut, et al.
Thrombosis Research|September 20, 2020
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 monthsGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
NPJ Genomic Medicine|February 7, 2024
A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genomeClaude Bhérer, Robert Eveleigh, Katerina Trajanoska, et al.
Cardiovascular Research|November 20, 2025
ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage like foam cells in atherosclerosisBryce R Evans, Julia Schulz, Vasiliki Triantafyllidou, et al.
Pageof 8